Maravai Lifesciences Holdings Inc (MRVI) Directors and Executive Officers

Officers & Directors

Executives:

- Carl Hull, Executive Chairman of the Board
- Kevin Herde, Chief Financial Officer (Principal Financial and Accounting Officer)

Directors:

- Anat Ashkenazi, Director
- Benjamin Daverman, Director
- Gregory T. Lucier, Director
- John DeFord, Director
- Jessica Hopfield, Director
- Luke Marker, Director
- Murali K. Prahalad, Director
- Sean Cunningham, Director
- Constantine Mihas, Director
- William E. Martin, III, Director
- Susannah Gray, Director ,

Maravai Lifesciences Holdings Inc currently has 435 employees.

News about Maravai Lifesciences Holdings Inc Key Personnel

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Maravai LifeSciences Welcomes Rajesh Asarpota as CFO Amidst Challenging TimesIn a move to bolster its leadership team, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI)—a global provider of life science reagents and services—has announced the appointment of Rajesh Raj Asarpota as the new Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. Asarpota succeeds Kevin Herde, who will transition to an advisory role on the same date, allowing him to facilitate a smooth transition of responsibilities.The announcement comes at a pivotal time for Maravai, which has faced increasing scrutiny from investors and legal challenges in recent months. Notably, Susannah Gray, Chair o...